The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesis
Abstract
Different fibronectin (FN) isoforms are generated by the alternative splicing of 3 regions (ED‐A, ED‐B and IIICS) of the primary transcript. The FN isoform containing the ED‐B sequence, a complete type‐III‐homology repeat, while having extremely restricted distribution in normal adult tissues, reveals high expression in fetal and tumor tissues. Using the monoclonal antibody (MAb) BC‐1, specific for the FN isoform containing the ED‐B sequence (B+·FN), we demonstrate here, using immunohistochemical techniques, that while this FN isoform is undetectable in mature vessels, it is highly expressed during angiogenesis both in neoplastic and in normal tissues, as in the case of the functional layer of endometrium during the proliferative phase. B+·FN is thus a marker for the formation of new vessels, and the BC‐I MAb may be a useful reagent for evaluating the level of the angiogenetic process in different neoplasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., & Gabbiani, G. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2787 · Cited by 1,621
Histological Typing of Tumours of the Central Nervous System
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Springer eBooks · doi:10.1007/978-3-642-84988-6 · Cited by 1,532
Ruoslahti, E. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002111 · Cited by 1,340
CELL SURFACE INTERACTIONS WITH EXTRACELLULAR MATERIALS
Yamada, K. M. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.003553 · Cited by 1,135
Capillary endothelial cell cultures: phenotypic modulation by matrix components.
Madri, J. A., & Williams, S. K. (1983) · The Journal of cell biology · doi:10.1083/jcb.97.1.153 · Cited by 612
Molecular Biology of Fibronectin
Hynes, R. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.000435 · Cited by 601
How does extracellular matrix control capillary morphogenesis?
Ingber, D. E., & Folkman, J. (1989) · Cell · doi:10.1016/0092-8674(89)90928-8 · Cited by 462
Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis
Risau, W., & Lemmon, V. (1988) · Developmental Biology · doi:10.1016/0012-1606(88)90225-4 · Cited by 401
Zardi, L., Carnemolla, B., Siri, A., Petersen, T. E., Paolella, G., Sebastio, G., & Baralle, F. E. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02509.x · Cited by 338
Self-citationCarnemolla, B., Balza, E., Siri, A., Zardi, L., Nicotra, M. R., Bigotti, A., & Natali, P. G. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.3.1139 · Cited by 335
Self-citation
Cited by
Interfering with pH regulation in tumours as a therapeutic strategy
Neri, D., & Supuran, C. T. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3554 · Cited by 1,547
Tumor angiogenesis: past, present and the near future
Kerbel, R. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.505 · Cited by 976
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Kim, S., Bell, K., Mousa, S. A., & Varner, J. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65005-5 · Cited by 635
Neri, D., & Bicknell, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1627 · Cited by 600
Heterogeneity of Endothelial Cells: Specific Markers
Garlanda, C., & Dejana, E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.7.1193 · Cited by 483
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
Fibronectins, Their Fibrillogenesis, and In Vivo Functions
Schwarzbauer, J. E., & DeSimone, D. W. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005041 · Cited by 445
Design and Use of a Phage Display Library
Pini, A., Viti, F., Santucci, A., Carnemolla, B., Zardi, L., Neri, P., & Neri, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21769 · Cited by 422
Self-citationSolinas, G., Schiarea, S., Liguori, M., Fabbri, M., Pesce, S., Zammataro, L., Pasqualini, F., Nebuloni, M., Chiabrando, C., Mantovani, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000413 · Cited by 370
Borsi, L., Balza, E., Bestagno, M., Castellani, P., Carnemolla, B., Biro, A., Leprini, A., Sepulveda, J., Burrone, O., Neri, D., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10662 · Cited by 355
Self-citationDelivering safer immunotherapies for cancer
Milling, L., Zhang, Y., & Irvine, D. J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.011 · Cited by 305
Carnemolla, B., Borsi, L., Balza, E., Castellani, P., Meazza, R., Berndt, A., Ferrini, S., Kosmehl, H., Neri, D., & Zardi, L. (2002) · Blood · doi:10.1182/blood.v99.5.1659 · Cited by 296
Self-citationXie, Y. J., Dougan, M., Jailkhani, N., Ingram, J., Fang, T., Kummer, L., Momin, N., Pishesha, N., Rickelt, S., Hynes, R. O., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817147116 · Cited by 296
Neri, D., Carnemolla, B., Nissim, A., Leprini, A., Querzè, G., Balza, E., Pini, A., Tarli, L., Halin, C., Neri, P., et al. (1997) · Nature Biotechnology · doi:10.1038/nbt1197-1271 · Cited by 282
Self-citationFibronectins in vascular morphogenesis
Astrof, S., & Hynes, R. O. (2009) · Angiogenesis · doi:10.1007/s10456-009-9136-6 · Cited by 271
Anticancer strategies involving the vasculature
Heath, V. L., & Bicknell, R. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.52 · Cited by 255
Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
Halin, C., Rondini, S., Nilsson, F., Berndt, A., Kosmehl, H., Zardi, L., & Neri, D. (2002) · Nature Biotechnology · doi:10.1038/nbt0302-264 · Cited by 252
Self-citationWhite, E. S., & Muro, A. F. (2011) · IUBMB Life · doi:10.1002/iub.493 · Cited by 174
“during physiological embryonic angiogenesis and tumor angiogenesis has been documented in several publications (22–24), encouraging the use of these domains as vascular markers of solid tumors and metastases (25, 26).”
BackgroundFibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging
Park, J., Kim, S., Saw, P. E., Lee, I.-H., Yu, M. K., Kim, M., Lee, K., Kim, Y.-C., Jeong, Y. Y., & Jon, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.029 · Cited by 48
Stroma in normal and cancer wound healing
Huet, E., Jaroz, C., Nguyen, H. Q., Belkacemi, Y., de la Taille, A., Stavrinides, V., & Whitaker, H. (2019) · The FEBS Journal · doi:10.1111/febs.14842 · Cited by 42
Targeting tumor extracellular matrix with nanoparticles to circumvent therapeutic resistance
Ding, X., Liang, Y., Zhou, S., Wu, Y., Sałata, P., Mikolajczk-Martinez, A., Khosrawipour, V., & Zhang, Z. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113786 · Cited by 20
Metadata
- Authors
- Castellani, P., Viale, G., Dorcaratto, A., Nicolo, G., Kaczmarek, J., Querze, G., & Zardi, L.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1994-12
- Volume
- 59
- Issue
- 5
- Pages
- 612-618
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2009507555
- Cited by
- 316
- References
- 23
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.